Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY   US02043Q1076

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
92.91(c) 94.25(c) 91.53(c) 94.72(c) 92.74(c) Last
659 451 855 794 759 131 466 563 909 666 Volume
-0.99% +1.44% -2.89% +3.49% -2.09% Change
More quotes
Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which develops novel therapeutics based on RNA interference.It is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including... 
Sector
Biotechnology & Medical Research
Calendar
11/06 | 03:45pmPresentation
Surperformance© rating of Alnylam Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALNYLAM PHARMACEUTICALS, I
Duration : Period :
Alnylam Pharmaceuticals, I Technical Analysis Chart | ALNY | US02043Q1076 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 33,6 M
EBIT 2014 -332 M
Net income 2014 -341 M
Finance 2014 737 M
Yield 2014 -
Sales 2015 50,8 M
EBIT 2015 -199 M
Net income 2015 -210 M
Finance 2015 698 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 193x
EV / Sales 2015 129x
Capitalization 7 232 M
More Financials
Latest news on ALNYLAM PHARMACEUTICALS, I
2d ago ALNYLAM PHARMACEUTICALS : to Webcast Presentation at the Nomura Biotechnology Co..
3d ago ALNYLAM PHARMACEUTICALS : to Webcast Conference Call Discussing Third Quarter 20..
3d ago ALNYLAM PHARMACEUTICALS : Launches Assist™, Dedicated to Providing Support..
3d ago ALNYLAM PHARMACEUTICALS : Appoints Pushkal Garg, M.D., Senior Vice President, Cl..
3d ago ALNYLAM PHARMACEUTICALS : Unveils Assist
4d ago ALNYLAM PHARMACEUTICALS : Assigned Patent
10/23 ALNYLAM PHARMACEUTICALS : Introduces Assist
10/22 ALNYLAM PHARMACEUTICALS : Reports Six-Month Clinical Data from Patisiran Phase 2..
10/20 ALNYLAM PHARMACEUTICALS : Launches Assist™, Dedicated to Providing Support..
10/16 ALNYLAM PHARMACEUTICALS : Posts Patisiran Study Data
10/14 ALNYLAM PHARMACEUTICALS : Presents New Clinical and Pre-Clinical Data on RNAi Th..
10/13 ALNYLAM PHARMACEUTICALS : Reports Six-Month Clinical Data from Patisiran Phase 2..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF